Compounds > soman
Page last updated: 2024-08-18

soman and Cognition Disorders

soman has been researched along with Cognition Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Béracochéa, D; Collombet, JM; Filliat, P; Lallement, G; Liscia, P; Piérard, C1
Albuquerque, EX; Kulkarni, GS; Mamczarz, J; Pereira, EF1
Alkalay, D; Brandeis, R; Cohen, G; Rabinovitz, I; Raveh, L; Sonego, H; Weissman, BA1
Alkalay, D; Brandeis, R; Cohen, G; Gilat, E; Rabinovitz, I; Raveh, L; Sonego, H; Weissman, BA1
Aas, P; Enger, S; Myhrer, T1
Ashani, Y; Brandeis, R; Cohen, E; Grunwald, J; Raveh, L1

Trials

1 trial(s) available for soman and Cognition Disorders

ArticleYear
Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.
    Neurotoxicology, 2002, Volume: 23, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cognition Disorders; Cyclopentanes; Escape Reaction; Hypoxia, Brain; Male; Maze Learning; Prosencephalon; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Soman; Swimming

2002

Other Studies

5 other study(ies) available for soman and Cognition Disorders

ArticleYear
Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice.
    Behavioural brain research, 2011, Aug-01, Volume: 221, Issue:1

    Topics: Amygdala; Animals; Cholinesterase Inhibitors; Cognition Disorders; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Epidermal Growth Factor; Fear; Fibroblast Growth Factor 2; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred Strains; Nerve Regeneration; Nerve Tissue Proteins; Nuclear Proteins; Soman

2011
Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance.
    Neurotoxicology, 2011, Volume: 32, Issue:6

    Topics: Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Extinction, Psychological; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Maze Learning; Motor Activity; Neuroprotective Agents; Nootropic Agents; Reaction Time; Soman; Time Factors

2011
Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction.
    Toxicological sciences : an official journal of the Society of Toxicology, 2003, Volume: 75, Issue:1

    Topics: Animals; Antidotes; Benzodiazepinones; Brain; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Disorders; Electroencephalography; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ligands; Male; Maze Learning; Radioligand Assay; Rats; Rats, Sprague-Dawley; Soman; Time Factors

2003
Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality.
    European journal of pharmacology, 2004, Jan-12, Volume: 483, Issue:2-3

    Topics: Animals; Cognition Disorders; Drug Therapy, Combination; Exploratory Behavior; Lethal Dose 50; Male; Physostigmine; Procyclidine; Rats; Rats, Wistar; Scopolamine; Soman

2004
Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:4

    Topics: Animals; Butyrylcholinesterase; Cognition Disorders; Half-Life; Humans; Male; Memory; Rats; Rats, Sprague-Dawley; Reversal Learning; Soman; Space Perception; Swimming

1993